GlassScriptPhysician profile
Melissa O Lewis
NPI 1912979295
$1,403.51
in general payments reported to CMS, 2019-2025
19 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $251 · 2023: $323 · 2024: $159 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $556.85 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3, Octrode |
| Sequel Med Tech, LLC | $186.00 | 2025 | Twiist |
| Novo Nordisk INC | $97.85 | 2021-2024 | Rybelsus, Ozempic |
| Corcept Therapeutics | $72.13 | 2021-2024 | Korlym |
| Galderma Laboratories, L.P. | $71.07 | 2022 | |
| Lilly USA, LLC | $60.57 | 2021-2023 | Mounjaro, Trulicity, Humulin |
| Amgen INC. | $57.74 | 2021-2025 | Repatha |
| Medtronic, INC. | $56.01 | 2021-2024 | Intellis Adaptivestim |
| Dexcom, INC. | $55.36 | 2021-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $32.42 | 2021 | |
| Radius Health, INC. | $27.51 | 2025 | |
| Abbvie INC. | $25.77 | 2021-2025 | |
| Ascendis Pharma Endocrinology INC | $22.10 | 2023 | |
| Sanofi-Aventis U.S. LLC | $15.85 | 2023 | |
| Amarin Pharma, INC. | $15.05 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.35 | 2021 | |
| Currax Pharmaceuticals LLC | $12.47 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.29 | 2021 | |
| Amneal Pharmaceuticals LLC | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.